Note 14 - Segment Information

12 Months Ended

Dec. 28, 2024

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

14.   SEGMENT INFORMATION

The Company follows ASC 280, “Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Consolidated Financial Statements).

The Company reports segment information based on the management approach, which designates the internal reporting used by the Chief Operating Decision Makers (“CODMs”), who were Bradley Vizi, Chief Executive Officer, and Kevin Miller. Chief Financial Officer. The Company’s CODMs are responsible for making decisions regarding the Company’s business, including resource allocations and performance assessments based on historical and future segment revenue, operating expenses, and operating income (loss) before interest and taxes.

The tables below summarize the results of operations and total assets by segment provided to the CODMs. Segment operating income (loss) includes selling, general, and administrative expenses directly attributable to that segment and charges for allocating corporate costs to each of the operating segments. Please refer to the segment discussion on pages 34 and 35 of the Management’s Discussion and Analysis of Financial Condition and Results of Operations section of this Annual Report on Form 10-K.

Fiscal Year Ended December 28, 2024	Specialty Health Care		Engineering		Life Sciences, Data & Solutions			Corporate			Total
Revenue	$	142,679	$	96,459	$	39,242		$	-		$	278,380
Cost of services		100,146		73,916		24,540			-			198,602
Gross profit		42,533		22,543		14,702			-			79,778
Selling, general and administrative		30,326		17,355		9,106			-			56,787
Depreciation and amortization of property and equipment		525		706		188			-			1,419
Amortization of acquired intangible assets		-		-		683			-			683
Potential stock issuance and financing transactions		-		-		-			323			323
Remeasurement of contingent consideration		-		-		(1,759	)		-			(1,759	)
Operating income	$	11,682	$	4,482	$	6,484		$	(323	)	$	22,325
Total assets as of December 28, 2024	$	43,180	$	52,160	$	22,210		$	14,527		$	132,077
Property and equipment acquired	$	296	$	691	$	28		$	1,557		$	2,572

Fiscal Year Ended December 30, 2023	Specialty Health Care		Engineering			Life Sciences, Data & Solutions		Corporate		Total
Revenue	$	136,241	$	84,675		$	42,321	$	-	$	263,237
Cost of services		96,309		64,071			26,161		-		186,541
Gross profit		39,932		20,604			16,160		-		76,696
Selling, general and administrative		26,010		16,964			9,211		-		52,185
Depreciation and amortization of property and equipment		383		504			145		-		1,032
Amortization of acquired intangible assets		-		-			182		-		182
Gain on sale of assets		-		(395	)		-		-		(395	)
Operating income (loss)	$	13,539	$	3,531		$	6,622	$	-	$	23,692
Total assets as of December 30, 2023	$	43,769	$	46,425		$	18,586	$	11,704	$	120,484
Property and equipment acquired	$	141	$	724		$	123	$	1,943	$	2,931

The Company derives a majority of its revenue from offices in the United States. Revenue reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Germany, Philippines, Puerto Rico and Europe. The Company does not derive any revenue in the Philippines. Revenue by geographic area for the fiscal years ended December 28, 2024 and December 30, 2023 are as follows:

	Fiscal Year Ended
	December 28,		December 30,
	2024		2023
Revenue
United States	$	256,759	$	246,578
Canada		7,196		6,480
Puerto Rico		7,017		6,515
Europe		7,408		3,664
Philippines		-		-
	$	278,380	$	263,237

Total assets by geographic area as of the reported periods are as follows:

	Fiscal Year Ended
	December 28,		December 30,
	2024		2023
Total Assets
United States	$	123,905	$	110,781
Canada		1,423		1,880
Puerto Rico		3,286		3,476
Europe		3,408		4,347
Philippines		55		-
	$	132,077	$	120,484